Alamar Biosciences, Inc. (ALMR)
ALMR Stock Price Chart
Explore Alamar Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze ALMR price movements and trends.
ALMR Company Profile
Discover essential business fundamentals and corporate details for Alamar Biosciences, Inc. (ALMR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Apr 2026
Employees
222.00
Website
www.alamarbio.comCEO
Justin J. McAnear
Description
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
ALMR Financial Timeline
Browse a chronological timeline of Alamar Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is -$0.36, while revenue estimate is $25.94m.
Earnings released on 8 May 2026
EPS came in at -$1.74 falling short of the estimated -$1.71 by -1.75%, while revenue for the quarter reached $26.00m , missing expectations by -0.03%.
ALMR Stock Performance
Access detailed ALMR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
